Hadeer Mohamed Rasheed

ORCID: 0000-0003-1010-296X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sepsis Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Cell death mechanisms and regulation
  • Acute Lymphoblastic Leukemia research
  • Clusterin in disease pathology
  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction

Humboldt-Universität zu Berlin
2024-2025

Charité - Universitätsmedizin Berlin
2024-2025

Freie Universität Berlin
2025

German Marine Research Consortium
2025

National Center for Tumor Diseases
2025

Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2025

Alexandria University
2021-2024

Background Previous data indicated that the leucine-rich α-2 glycoprotein 1 (LRG1) pathway contributes to vascular dysfunction during cancer growth. Therapeutic targeting of LRG1 normalized tumor vessel and enhanced efficacy anti-cancer adoptive T cell therapy. A major clinical problem after allogeneic hematopoietic stem transplantation (alloHSCT) chimeric antigen receptor (CAR) T-cell therapy is induction hyperinflammatory side effects, which are typically associated with severe endothelial...

10.1136/jitc-2024-009372 article EN cc-by-nc-nd Journal for ImmunoTherapy of Cancer 2025-03-01

We sought to identify leukemia-associated immunophenotypes (LAIPs) in 50 acute myeloid leukemia (AML) patients at diagnosis using an eight-color multiparameter flow cytometry (MFC) panel and detect if they showed any alteration relapsed/refractory cases.We used the MFC with CD45/side scatter log gating strategy analyze LAIPs AML presenting Alexandria University Hospitals, Egypt relapse refractory cases. Twenty age sex matched bone marrow samples from performing aspirate for non-malignant...

10.5001/omj.2021.108 article EN cc-by-nc Oman Medical Journal 2021-10-18
Coming Soon ...